Ligand validation:6BKP

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6BKP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BKP_NAG_A_409	24%	48%	0.208	0.838	0.54	1.44	-	2	0	0	100%	0.9333
6BKP_NAG_A_403	22%	71%	0.242	0.857	0.3	0.8	-	-	0	0	100%	0.9333
6BKP_NAG_A_410	0%	68%	0.557	0.564	0.38	0.83	-	1	3	0	100%	0.9333
6BKO_NAG_A_411	70%	60%	0.108	0.926	0.53	0.98	-	1	0	0	100%	0.9333
6BKS_NAG_A_412	60%	57%	0.153	0.94	0.46	1.17	-	3	0	0	100%	0.9333
4WE7_NAG_C_303	55%	67%	0.135	0.902	0.48	0.77	-	1	0	0	100%	0.9333
4O5N_NAG_A_408	49%	55%	0.169	0.916	0.62	1.1	-	1	0	0	100%	0.9333
8TJA_NAG_A_403	48%	74%	0.146	0.889	0.5	0.52	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.